At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ABVX Abivax S.A.
Trading 03-30 09:56:48 EDT
103.15
+0.68
+0.66%
High104.80Low103.00Vol130.10K
Open103.59D1 Closing102.47Amplitude1.76%
Mkt Cap8.17BTradable Cap4.40BTotal Shares79.19M
T/O13.50MT/O Rate0.31%Tradable Shares42.66M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst
TIPRANKS  ·  03-28 22:37
Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst
Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim
TIPRANKS  ·  03-25
Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim
Stock Track | Abivax Plummets 5.33% Intraday as CEO Downplays Sale Talk and Eyes Capital Raise
Stock Track  ·  03-25
Stock Track | Abivax Plummets 5.33% Intraday as CEO Downplays Sale Talk and Eyes Capital Raise
Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears
Benzinga_recent_news  ·  03-25
Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX)
TIPRANKS  ·  03-24
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX)
Abivax price target raised to $148 from $142 at Barclays
TIPRANKS  ·  03-24
Abivax price target raised to $148 from $142 at Barclays
Abivax SA reports results for the quarter ended December 31 - Earnings Summary
Reuters  ·  03-24
Abivax SA reports results for the quarter ended December 31 - Earnings Summary
Abivax 2025 Net Loss Widens
MT Newswires Live  ·  03-24
Abivax 2025 Net Loss Widens
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  03-23
Calendar of U.S. Earnings Expected in the Week Ahead
LifeSci Capital Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)
TIPRANKS  ·  03-21
LifeSci Capital Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  03-20
Calendar of U.S. Earnings Expected in the Week Ahead
Abivax SA expected to post a loss of €1.28 a share - Earnings Preview
Reuters  ·  03-20
Abivax SA expected to post a loss of €1.28 a share - Earnings Preview
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  03-18
Calendar of U.S. Earnings Expected in the Week Ahead
European Equities Traded in the US as American Depositary Receipts Higher Monday
MT Newswires Live  ·  03-16
European Equities Traded in the US as American Depositary Receipts Higher Monday
Jefferies Initiates Abivax at Buy With $160 Price Target
MT Newswires Live  ·  03-16
Jefferies Initiates Abivax at Buy With $160 Price Target
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics
Reuters  ·  03-16
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics
Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 29.21%, and institutional views are bullish
Earnings Agent  ·  03-16
Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 29.21%, and institutional views are bullish
Abivax SA Sponsored ADR (ABVX) Initiated with a Buy at Leerink Partners
TIPRANKS  ·  03-16
Abivax SA Sponsored ADR (ABVX) Initiated with a Buy at Leerink Partners
Abivax initiated with a Buy at Jefferies
TIPRANKS  ·  03-16
Abivax initiated with a Buy at Jefferies
Barclays Remains a Buy on Abivax SA Sponsored ADR (ABVX)
TIPRANKS  ·  03-13
Barclays Remains a Buy on Abivax SA Sponsored ADR (ABVX)

Introduction

Company Name.
Abivax S.A.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Issue price:
--